As the field matures, the most transformative gene therapies in heart health are treating delivery not as an afterthought but as a fundamental principle.
- Inside SynaptixBio's Mission To Develop A Therapy For H-ABC
- 5 QMS Blind Spots You Should Know About
- New MIT Consortium Links Innovation With Real-World Biomanufacturing
- Injecting Cancer Killers: Intratumoral Therapy For Solid Tumors
- Proteomics Tools: A Resurrection
- Powering AI And Synthetic Biology In Therapy Design
- Six Specialized Modalities Testing CDMO Readiness In 2026
- Green Supply Chains Rarely Start With A Pledge; Target Waste Instead
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Rapidly Assess Drug Response In 2D And 3D Breast Cancer Model Systems
For years, 2D cell cultures have been crucial in drug discovery. Explore how 3D cultures offer more biologically relevant models today that enhance cancer research and drug efficacy assessments.
-
Media Exchange In iPSC Cell Expansion And Differentiation: A Comparative Study
Low-shear, closed-system media exchange in iPSC differentiation is vital for scalability. This study compares automated centrifugation to gravity sedimentation, showing equivalent or superior differentiation outcomes.
-
Expert Insights In Navigating CGT's Complex Supply Chain
Examine insights shared during Cencora's ThinkLive Cell and Gene Therapy Summit 2024 that shed light on the challenges and opportunities in navigating the complexities of the cell and gene supply chain.
-
Accelerating Clinical Data Review With Traceable Workflows
Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.
-
High-Performance Extraction And Quantitation Of Host-Cell Residual DNA
This study presents a high-efficiency method for extracting and quantifying residual DNA from host cells using a semi-automated, high-throughput workflow.
-
Innovating The mAb Characterization Process
Understanding the characteristics of a molecule's "personality" is crucial for optimizing development and manufacturing. Learn how to overcome the challenges in the characterization process.
-
Ensuring cGMP Compliance In Cell And Gene Therapy Manufacturing
Discover how adhering to strict GMP guidelines and advanced equipment design ensures that complex, sterile cell and gene therapies are safely and effectively delivered.
-
TFF Cassettes With 100 kDa Membranes For RNA And LNP Applications
This study showcases the performance of regenerated cellulose flat sheet membranes with a 100 kDa molecular weight cutoff for UF/DF of RNA molecules by TFF.
-
The Value Of Peptones For Cost-Effective Vaccine Manufacturing
Peptones offer a strategic solution to key biomanufacturing challenges by enhancing cell culture performance, improving yields, and reducing production costs.
-
A Beginner's Guide To Mesenchymal Stem Cell Culture
Gain a foundational understanding of the process for culturing mesenchymal stem cells in stirred-tank bioreactors and learn about the key parameters for successful scale-up.
NEWSLETTER ARCHIVE
- 03.11.26 -- Are You Scaling CGT Wrong?
- 03.11.26 -- Regulators Maintain Consistent Endpoints While Raising Evidence Standards
- 03.10.26 -- STREAM Edition: mRNA Hot Takes: Fighting Complacency And "Alternative Facts" In 2026
- 03.10.26 -- The Real Reason We Haven't Fully Automated Cell Therapy Yet
- 03.09.26 -- Putting Pressure On CDMOs With Herman Bozenhardt
CELL AND GENE CONTENT COLLECTIONS
While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections